title: Euglycemic hyperinsulinemic clamp to assess posthepatic glucose appearance after carbohydrate loading. 2. Evaluation of corn and mung bean starches in healthy men.
abstract: BACKGROUND
  The rate of absorption of glucose from carbohydrates is important in several aspects of health. We recently validated a noninvasive technique in pigs, euglycemic hyperinsulinemic clamp plus oral carbohydrate loading (OC-Clamp), to quantify the rate of net posthepatic appearance of glucose after ingestion of carbohydrates.
  
  
  OBJECTIVE
  The OC-Clamp procedure was performed in 8 healthy men to compare the net posthepatic appearance of glucose after ingestion of 1 of 3 carbohydrates.
  
  
  METHODS
  Human volunteers underwent the OC-Clamp procedure at an insulin infusion rate of 1.5 mU x kg(-1) x min(-1) (n = 5). The oral carbohydrate load (1 g/kg) consisted of glucose, cornstarch, or mung bean starch. During the OC-Clamp procedure, the glucose infusion rate decreased during absorption to maintain plasma glucose steady state and the decrease reflected the net posthepatic appearance of glucose. In addition, carbohydrates were loaded without insulin infusion (n = 6) and glycemic indexes were calculated (with glucose as the reference).
  
  
  RESULTS
  The mean (+/-SEM) glycemic index of cornstarch was higher (95 +/- 18) than that of mung bean starch (51 +/- 13). In the OC-Clamp experiments, the posthepatic appearance of glucose and cornstarch did not differ significantly and represented 79.4 +/- 5.0% and 72.6 +/- 4.0%, respectively, of the load after complete absorption (within 3 h). In contrast, the net posthepatic appearance of glucose from mung bean starch was significantly lower (35.6 +/- 4.6% of the load, P < 0.001) than that from glucose and cornstarch, even 4.5 h postprandially.
  
  
  CONCLUSIONS
  The OC-Clamp technique allows a continuous assessment of net posthepatic appearance of glucose after ingestion of carbohydrates and significant discrimination between corn and mung bean starches.
authors.affiliation: INSERM U 341, Service de Diabétologie, Hôpital Hôtel-Dieu, Paris, France.
authors.forename: V
authors.initials: V
authors.lastname: Lang
authors.forename: F R
authors.initials: FR
authors.lastname: Bornet
authors.forename: P
authors.initials: P
authors.lastname: Vaugelade
authors.forename: M
authors.initials: M
authors.lastname: van Ypersele de Strihou
authors.forename: J
authors.initials: J
authors.lastname: Luo
authors.forename: N
authors.initials: N
authors.lastname: Pacher
authors.forename: F
authors.initials: F
authors.lastname: Rossi
authors.forename: P
authors.initials: P
authors.lastname: La Droitte
authors.forename: P H
authors.initials: PH
authors.lastname: Duée
authors.forename: G
authors.initials: G
authors.lastname: Slama
mesh_terms: D000704:Analysis of Variance; D001682:Biological Availability; D001786:Blood Glucose; D002096:C-Peptide / Q000097:blood; D004040:Dietary Carbohydrates / Q000378:metabolism / Q000493:pharmacokinetics*; D007887:Fabaceae / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D015309:Glucose Clamp Technique; D006801:Humans; D007328:Insulin / Q000097:blood; D007408:Intestinal Absorption; D008099:Liver / Q000378:metabolism*; D008297:Male; D010946:Plants, Medicinal; D013213:Starch / Q000378:metabolism / Q000493:pharmacokinetics*
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D004040:Dietary Carbohydrates; D007328:Insulin; D013213:Starch; D005947:Glucose